Literature DB >> 20019190

The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways.

Carlos S Moreno1.   

Abstract

The transforming growth factor beta, Hedgehog, Notch, and Wnt signaling pathways all play critical roles in the development and progression of prostate cancer. It is becoming increasingly apparent that these pathways may intersect with developmentally important transcription factors such as the sex-determining region Y-box 4 (SOX4), homeobox C6, enhancer of zeste 2, and ETS-related gene, which are up-regulated in prostate cancers. For example, identification of the downstream targets of SOX4 and homeobox C6 suggests that these factors may cooperate to activate the Notch pathway and the PI3K/AKT pathway, possibly in response to Wnt signals. PI3K/AKT activation likely occurs indirectly via up-regulation of growth factor receptors, while Notch activation is secondary to up-regulation of Notch pathway components. In addition, SOX4 may affect terminal differentiation via regulation of other transcription factors such as NKX3.1 and MLL, and regulation of components of the microRNA pathway such as Dicer and Argonaute 1. The evidence supporting activation of these pathways in prostate cancer progression suggests that combinations of compounds targeting them may be of benefit to patients with aggressive, metastatic disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20019190      PMCID: PMC2808058          DOI: 10.2353/ajpath.2010.090657

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  129 in total

1.  Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow.

Authors:  A Bafico; G Liu; A Yaniv; A Gazit; S A Aaronson
Journal:  Nat Cell Biol       Date:  2001-07       Impact factor: 28.824

2.  Expression profiling reveals hepsin overexpression in prostate cancer.

Authors:  J A Magee; T Araki; S Patil; T Ehrig; L True; P A Humphrey; W J Catalona; M A Watson; J Milbrandt
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

3.  Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling.

Authors:  J Luo; D J Duggan; Y Chen; J Sauvageot; C M Ewing; M L Bittner; J M Trent; W B Isaacs
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

4.  Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.

Authors:  J B Welsh; L M Sapinoso; A I Su; S G Kern; J Wang-Rodriguez; C A Moskaluk; H F Frierson; G M Hampton
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

Review 5.  Homeobox genes in normal and malignant cells.

Authors:  C Cillo; M Cantile; A Faiella; E Boncinelli
Journal:  J Cell Physiol       Date:  2001-08       Impact factor: 6.384

6.  Delineation of prognostic biomarkers in prostate cancer.

Authors:  S M Dhanasekaran; T R Barrette; D Ghosh; R Shah; S Varambally; K Kurachi; K J Pienta; M A Rubin; A M Chinnaiyan
Journal:  Nature       Date:  2001-08-23       Impact factor: 49.962

7.  Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway.

Authors:  Jean-Marc Ricort; Michel Binoux
Journal:  J Biol Chem       Date:  2002-04-08       Impact factor: 5.157

8.  Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue.

Authors:  Thomas Ernst; Manfred Hergenhahn; Marc Kenzelmann; Clemens D Cohen; Mahnaz Bonrouhi; Annette Weninger; Ralf Klären; Elisabeth F Gröne; Manfred Wiesel; Christof Güdemann; Jens Küster; Winfried Schott; Gerd Staehler; Matthias Kretzler; Monica Hollstein; Hermann-Josef Gröne
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

Review 9.  Role of androgens and fibroblast growth factors in prostatic development.

Authors:  A A Thomson
Journal:  Reproduction       Date:  2001-02       Impact factor: 3.906

10.  Activation of the hedgehog pathway in advanced prostate cancer.

Authors:  Tao Sheng; Chengxin Li; Xiaoli Zhang; Sumin Chi; Nonggao He; Kai Chen; Frank McCormick; Zoran Gatalica; Jingwu Xie
Journal:  Mol Cancer       Date:  2004-10-13       Impact factor: 27.401

View more
  34 in total

1.  Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer.

Authors:  Farhad Kosari; John C Cheville; Cristiane M Ida; R Jeffrey Karnes; Alexey A Leontovich; Thomas J Sebo; Sibel Erdogan; Erika Rodriguez; Stephen J Murphy; George Vasmatzis
Journal:  Am J Pathol       Date:  2012-05-26       Impact factor: 4.307

2.  JunD Is Required for Proliferation of Prostate Cancer Cells and Plays a Role in Transforming Growth Factor-β (TGF-β)-induced Inhibition of Cell Proliferation.

Authors:  Ana Cecilia Millena; BaoHan T Vo; Shafiq A Khan
Journal:  J Biol Chem       Date:  2016-06-29       Impact factor: 5.157

3.  Novel epigenetic determinants of type 2 diabetes in Mexican-American families.

Authors:  Hemant Kulkarni; Mark Z Kos; Jennifer Neary; Thomas D Dyer; Jack W Kent; Harald H H Göring; Shelley A Cole; Anthony G Comuzzie; Laura Almasy; Michael C Mahaney; Joanne E Curran; John Blangero; Melanie A Carless
Journal:  Hum Mol Genet       Date:  2015-06-22       Impact factor: 6.150

4.  Involvement of RARRES3 in the regulation of Wnt proteins acylation and signaling activities in human breast cancer cells.

Authors:  T-H Hsu; S-Y Jiang; W-L Chang; W-L Chan; R L Eckert; T M Scharadin; T-C Chang
Journal:  Cell Death Differ       Date:  2014-11-07       Impact factor: 15.828

5.  Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.

Authors:  Dingmiao Wang; Ting Hao; Yang Pan; Xiaowei Qian; Daixing Zhou
Journal:  Mol Cell Biochem       Date:  2015-01-08       Impact factor: 3.396

6.  Mutation of murine Sox4 untranslated regions results in partially penetrant perinatal lethality.

Authors:  Walter Guy Wiles; Zhongming Mou; Yang Du; Alyssa B Long; Christopher D Scharer; Birdal Bilir; Demetri D Spyropoulos; Nancy A Jenkins; Neal G Copeland; W David Martin; Carlos S Moreno
Journal:  In Vivo       Date:  2014 Sep-Oct       Impact factor: 2.155

7.  The role of upregulated miRNAs and the identification of novel mRNA targets in prostatospheres.

Authors:  Stephanie M Cabarcas; Suneetha Thomas; Xiaohu Zhang; James M Cherry; Thomas Sebastian; Subu Yerramilli; Eric Lader; William L Farrar; Elaine M Hurt
Journal:  Genomics       Date:  2011-12-20       Impact factor: 5.736

Review 8.  Targeting the PI3K pathway for cancer therapy.

Authors:  Navid Sadeghi; David E Gerber
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

9.  Inhibition of melanoma cell proliferation by targeting Wnt/β-catenin pathway through Sox4 RNA interference.

Authors:  Huahua Cai; Anhong Ni; Wen Li; Jiawen Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

Review 10.  SOX4 is a potential prognostic factor in human cancers: a systematic review and meta-analysis.

Authors:  J Chen; H L Ju; X Y Yuan; T J Wang; B Q Lai
Journal:  Clin Transl Oncol       Date:  2015-08-07       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.